These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 27629435)
21. Src signaling links mediators of inflammation to Cx43 gap junction channels in primary and transformed CFTR-expressing airway cells. Huang S; Jornot L; Wiszniewski L; Rochat T; Suter S; Lacroix JS; Chanson M Cell Commun Adhes; 2003; 10(4-6):279-85. PubMed ID: 14681029 [TBL] [Abstract][Full Text] [Related]
22. Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota. Fiorotto R; Strazzabosco M Cell Mol Gastroenterol Hepatol; 2019; 8(2):197-207. PubMed ID: 31075352 [TBL] [Abstract][Full Text] [Related]
25. Assessment of the efficacy of in vivo CFTR protein replacement therapy in CF mice. Ramjeesingh M; Huan LJ; Wilschanski M; Durie P; Li C; Gyomorey K; Wang Y; Kent G; Tanswell KA; Cutz E; Ackerley C; Bear CE Hum Gene Ther; 1998 Mar; 9(4):521-8. PubMed ID: 9525313 [TBL] [Abstract][Full Text] [Related]
26. Overexpression of RANKL in osteoblasts: a possible mechanism of susceptibility to bone disease in cystic fibrosis. Delion M; Braux J; Jourdain ML; Guillaume C; Bour C; Gangloff S; Pimpec-Barthes FL; Sermet-Gaudelus I; Jacquot J; Velard F J Pathol; 2016 Sep; 240(1):50-60. PubMed ID: 27235726 [TBL] [Abstract][Full Text] [Related]
28. Regulation of gap junctional communication by a pro-inflammatory cytokine in cystic fibrosis transmembrane conductance regulator-expressing but not cystic fibrosis airway cells. Chanson M; Berclaz PY; Scerri I; Dudez T; Wernke-Dollries K; Pizurki L; Pavirani A; Fiedler MA; Suter S Am J Pathol; 2001 May; 158(5):1775-84. PubMed ID: 11337375 [TBL] [Abstract][Full Text] [Related]
29. Expression of cystic fibrosis transmembrane conductance regulator in human gallbladder epithelial cells. Dray-Charier N; Paul A; Veissiere D; Mergey M; Scoazec JY; Capeau J; Brahimi-Horn C; Housset C Lab Invest; 1995 Dec; 73(6):828-36. PubMed ID: 8558844 [TBL] [Abstract][Full Text] [Related]
35. Defective regulation of gap junctional coupling in cystic fibrosis pancreatic duct cells. Chanson M; Scerri I; Suter S J Clin Invest; 1999 Jun; 103(12):1677-84. PubMed ID: 10377174 [TBL] [Abstract][Full Text] [Related]
36. Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation. Maiuri L; Luciani A; Giardino I; Raia V; Villella VR; D'Apolito M; Pettoello-Mantovani M; Guido S; Ciacci C; Cimmino M; Cexus ON; Londei M; Quaratino S J Immunol; 2008 Jun; 180(11):7697-705. PubMed ID: 18490773 [TBL] [Abstract][Full Text] [Related]
37. Defective activation of c-Src in cystic fibrosis airway epithelial cells results in loss of tumor necrosis factor-alpha-induced gap junction regulation. Huang S; Dudez T; Scerri I; Thomas MA; Giepmans BN; Suter S; Chanson M J Biol Chem; 2003 Mar; 278(10):8326-32. PubMed ID: 12506110 [TBL] [Abstract][Full Text] [Related]
38. Impaired regulatory volume decrease in freshly isolated cholangiocytes from cystic fibrosis mice: implications for cystic fibrosis transmembrane conductance regulator effect on potassium conductance. Cho WK; Siegrist VJ; Zinzow W J Biol Chem; 2004 Apr; 279(15):14610-8. PubMed ID: 14722124 [TBL] [Abstract][Full Text] [Related]
39. Transport systems in cholangiocytes: their role in bile formation and cholestasis. Strazzabosco M Yale J Biol Med; 1997; 70(4):427-34. PubMed ID: 9626763 [TBL] [Abstract][Full Text] [Related]